QIAGEN has received FDA clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, enabling detection of 20 pathogens and 10 antimicrobial resistance markers from positive blood cultures in about one hour.
Read More
A Labcorp survey of 148 US pathologists reports rising cancer rates are driving demand for digital pathology and genomic testing, but reimbursement and workforce shortages remain significant barriers to technology adoption.
Read More
Tel Aviv University researchers have developed a low-cost blood test that detects lung cancer by analyzing optical DNA fingerprints, achieving 93.1% sensitivity and 90.3% specificity.
Read More
Researchers at MUSC Hollings Cancer Center have developed the ADLiB liquid biopsy platform, which uses machine learning to prioritize lymphoma diagnosis, identifying high-risk patients with up to 95% accuracy.
Read More
The FDA has approved Labcorp’s PGDx elio tissue complete CDx, a kit-based NGS companion diagnostic, to identify BRAF variants and guide targeted therapy selection for patients with advanced melanoma.
Read More